SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-97-003460
Filing Date
1997-08-14
Accepted
1997-08-14 00:00:00
Documents
4
Period of Report
1997-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. 10-Q 34394
2 STATEMENT RE: COMPUTATION OF LOSS PER SHARE EX-11 3239
3 FINANCIAL DATA SCHEDULE EX-27 2405
4 IMPORTANT FACTORS RE: FORWARD LOOKING STATEMENTS EX-99 32243
  Complete submission text file 0000950135-97-003460.txt   73981
Mailing Address
Business Address 195 ALBANY STREET CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 97659846
SIC: 2836 Biological Products, (No Diagnostic Substances)